[Anthrax: early steps of the intracellular stage of infection development].
It was shown that spore germination of different Bacillus anthracis strains in macrophage-like cells J774A.1 depended on the genotype of the strains. The virulent B. anthracis strains contain plasmids pXO1 and pX02 responsible for the synthesis of a toxin and a capsule, respectively. The loss of one of the plasmids results in the reduction of strain virulence. It was shown that effective survival of germinating spores in macrophages occurred in the presence of plasmid pXO1 only. The spores of the B. anthracis strains ?Ames and STI-Rif deprived of plasmid pXO1 were least adapted to passing through the intracellular stage. The B. anthracis strains 81/1 and 71/12 (carrying plasmids pXO1 and pXO2 and synthesizing the toxin and capsule) less effectively survived in the cytoplasm of macrophages than the strain STI-1 which has only the plasmid pXO1. It was found that the rate of synthesis of the capsule consisting of polymer gamma-D-glutamic acid depended on the ability of bacterial cells to escape from macrophages. In the B. anthracis strains carrying plasmid pXO2, capsule synthesis by vegetative cells was activated within macrophages that promoted a rapid escape of the vegetative cells from the macrophages. On the contrary, most of capsule-free cells of the vaccine strain STI-1 remained inside macrophages during the whole period of observation. Thus, integrated regulation of two processes, namely synthesis of the toxin components participating in the transition of the germinating cell from phagosome into cytoplasm, and synthesis of the capsule whose presence promotes rapid escape of bacterial cells from macrophages by presently unknown mechanism play the key role in anthrax development at early stages.
Bakhteeva
I V
IV
Titareva
G M
GM
Kravchenko
T B
TB
Mironova
R I
RI
Noskov
A N
AN
D000818:Animals; D000881:Anthrax / Q000382:microbiology; D022122:Anthrax Vaccines / Q000235:genetics; D001408:Bacillus anthracis / Q000235:genetics* / Q000472:pathogenicity* / Q000502:physiology; D001426:Bacterial Proteins / Q000378:metabolism; D002478:Cells, Cultured; D008264:Macrophages / Q000382:microbiology; D051379:Mice; D010957:Plasmids / Q000235:genetics; D011099:Polyglutamic Acid / Q000378:metabolism; D013045:Species Specificity; D013171:Spores, Bacterial / Q000166:cytology / Q000235:genetics / Q000472:pathogenicity*; D015534:Trans-Activators / Q000378:metabolism
C082932:ATXA protein, Bacillus anthracis; D022122:Anthrax Vaccines; D001426:Bacterial Proteins; D015534:Trans-Activators; D011099:Polyglutamic Acid